Pro Medic Secures $16M, 5‑Year Renewal With Ohio State, Adding Cardiology & Workflow Platforms

Executive Summary

Pro Medic Limited has extended a five‑year partnership with the Ohio State University Wexner Medical Center, valuing the renewal at approximately A$16 million. The new agreement expands the existing collaboration to include the Visage 7 Workflow and Visage 7 Cardiology Imaging platforms, and adopts a transaction‑based pricing model that offers potential upside for both parties. The contract also incorporates increased minimums and a higher fee per transaction than the previous term. Company leadership cites the renewal as evidence of strong demand for the Visage 7 Enterprise Imaging Platform, noting that total client‑renewals for the fiscal year now reach A$141 million.

The deal reflects Pro Medic’s strategy to replace legacy imaging systems with integrated, cloud‑based solutions that enhance clinical workflow, data accessibility, and diagnostic accuracy. By aligning revenue with the volume of services rendered, Pro Medic is moving toward value‑driven agreements that mirror the benefits delivered to healthcare institutions.

Background

Pro Medic Limited is a global provider of enterprise imaging solutions, specializing in radiology, pathology, and cardiology workflows. Its flagship product, the Visage 7 Enterprise Imaging Platform, is designed to support the transition from disparate, modality‑specific PACS to a unified, cloud‑enabled ecosystem. The platform’s architecture facilitates rapid data exchange, advanced analytics, and interoperability with electronic health records (EHRs) and clinical decision support tools.

Ohio State University Wexner Medical Center (OSUWMC) is a leading academic medical center that routinely evaluates new imaging technologies to improve patient outcomes and operational efficiency. The renewed partnership builds on a successful prior collaboration that demonstrated measurable improvements in image turnaround times, diagnostic confidence, and staff satisfaction.

Agreement Details

The transaction‑based model means that OSUWMC pays Pro Medic based on the number of imaging studies processed through the Visage 7 platforms. This structure encourages Pro Medic to optimize platform performance and throughput, directly linking revenue to the volume of clinically relevant imaging data generated.

Clinical Implications

1. Enhanced Workflow Efficiency

• The Visage 7 Workflow module streamlines image capture, transfer, and annotation, reducing the time from acquisition to interpretation. Clinical trials have shown a 15‑20 % reduction in report turnaround times when utilizing workflow‑optimized systems.

2. Cardiac Imaging Advancements

• The Visage 7 Cardiology Imaging platform provides automated plaque quantification, coronary flow reserve analysis, and machine‑learning–assisted interpretation. Evidence from multicenter studies indicates that AI‑augmented cardiology imaging can improve diagnostic sensitivity for coronary artery disease by up to 12 % without compromising specificity.

3. Integration with EHRs

• Seamless embedding of imaging data into the OSUWMC’s EHR enables clinicians to review studies in context with laboratory results, medication histories, and clinical notes, thereby supporting more informed decision-making.

4. Scalability for Hospital Systems

• The cloud‑based architecture allows OSUWMC to scale its imaging services during peak periods (e.g., post‑operative imaging) without requiring additional on‑premise hardware, thereby reducing capital expenditure and operational costs.

Safety and Efficacy

The clinical evidence supports that transitioning to the Visage 7 platforms does not compromise image quality or patient safety. Instead, it delivers measurable benefits in workflow efficiency and diagnostic accuracy, which are key drivers of improved patient outcomes in imaging‑intensive specialties.

Regulatory Considerations

1. FDA Classification

• The Visage 7 platforms are classified as Class II medical devices, requiring 510(k) clearance. Pro Medic has maintained continuous compliance with post‑market surveillance requirements.

2. HIPAA and Data Security

• The cloud infrastructure complies with HIPAA’s Security Rule, employing end‑to‑end encryption, multi‑factor authentication, and regular penetration testing.

3. International Standards

• ISO 13485 certification for quality management systems and ISO 14971 for risk management are upheld across all product lines.

4. Emerging Regulations

• Pro Medic is monitoring the evolving landscape of AI‑driven diagnostic tools, preparing for forthcoming FDA guidance on “Software as a Medical Device” (SaMD) and EU MDR requirements for software modules.

Market Impact

• Share Price Movement

• Despite modest declines in the Australian market and a brief pullback in U.S. technology indices, Pro Medic’s renewal contract contributes positively to its revenue outlook and client‑renewal pipeline.

• Competitive Positioning

• The deal reinforces Pro Medic’s standing among U.S. academic medical centers, enhancing its portfolio against competitors offering legacy PACS or hybrid solutions.

• Future Growth Prospects

• The transaction‑based model and increased per‑transaction fee signal a shift toward higher value agreements. Combined with a strong client‑retention rate, this positions the company for sustained revenue growth in the rapidly expanding digital imaging sector.

Conclusion

The five‑year renewal between Pro Medic Limited and OSUWMC exemplifies the successful integration of advanced imaging workflows into a major academic medical center. By expanding the partnership to include specialized cardiology modules and adopting a value‑aligned pricing strategy, Pro Medic reinforces its commitment to delivering evidence‑based, clinically impactful imaging solutions. The deal’s focus on safety, efficacy, and regulatory compliance aligns with the rigorous standards required in healthcare, while the financial terms and renewed client base support the company’s continued penetration and growth in the U.S. market.